China Biotech Services Announces Executive Director He Xun’s Resignation Effective 1 May 2026

Bulletin Express
Apr 30

China Biotech Services Holdings Limited disclosed that Executive Director He Xun has tendered his resignation, effective 1 May 2026, citing other business commitments requiring greater attention.

The company confirmed that He Xun has no disagreements with the board, and no matters need to be brought to the attention of The Stock Exchange of Hong Kong Limited or shareholders in relation to his departure. The board expressed sincere gratitude for He Xun’s contributions during his tenure.

As of the announcement date (30 April 2026), the board comprises four executive directors—Liu Xiaolin (Chairman), He Xun, Huang Song and Yin Ye—and three independent non-executive directors—Yan Guoxiang, Guo Yuantao and Zhang Xiao.

The notice will remain available on the HKEX website for at least seven days and on the company’s website at www.cbshhk.com.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10